Can metronidazole cause neurological problems?
Apart from peripheral neuropathy, metronidazole can also cause symptoms of central nervous system dysfunction like ataxic gait, dysarthria, seizures, and encephalopathy which may result from both short term and chronic use of this drug and is collectively termed as “metronidazole induced encephalopathy”(MIE).
Is neuropathy from Flagyl reversible?
Peripheral neuropathy is the most common adverse neurologic effect caused by metronidazole. Most of the adverse effects are reversible within weeks of discontinuation of treatment.
Is neuropathy a side effect of flagyl?
Metronidazole is a commonly used antibiotic prescribed for the treatment of anaerobic and protozoal infections of the gastrointestinal and genitourinary tracts. It is associated with numerous neurologic complications, including peripheral neuropathy.
Can metronidazole cause a stroke?
Metronidazole induced encephalopathy (MIE), an encephalopathy brought by an antibiotic, is characterized with cerebellar dysfunction, altered mental status and extrapyramidal symptoms. MIE can result in an acute manifestation, but MIE has not been reported as a stroke mimic.
How do you stop neurotoxicity?
The treatment approach to neurotoxicity is elimination or reduction of the toxic substance and therapy to relieve symptoms or provide support. Treatment may also involve avoiding air, food and water pollutants.
How do you fix neurotoxicity?
Treatment involves eliminating or reducing exposure to the toxic substance, followed by symptomatic and supportive therapy. Treatment involves eliminating or reducing exposure to the toxic substance, followed by symptomatic and supportive therapy.
Can I take probiotics while on metronidazole?
Using metroNIDAZOLE together with lactobacillus acidophilus may decrease the effects of lactobacillus acidophilus when these medications are taken at the same time. To prevent or minimize the interaction, lactobacillus acidophilus should be administered at least 1 to 2 hours before or after metroNIDAZOLE.
